Adam Houghton

Adam is currently AbbVie Vice-President, Corporate Strategy and Head of AbbVie Ventures, prior to this, he was Senior Director and Head, Immunology Search and Evaluation, focused on AbbVie’s externally sourced Immunology pipeline, from early-stage venture investments and strategic partnerships to late-stage clinical collaborations. Adam has over 30 years of experience in the Pharma industry, his previous roles include external innovation positions at Biogen and Eli Lilly, and drug discovery positions at P&G Pharmaceuticals and Zeneca Pharmaceuticals (now AstraZeneca).